J. S. Yadav et al. / Tetrahedron Letters 49 (2008) 3330–3334
3333
Ts
N+
O+ Ga(III)
H
Ts
-
I
N
I
TsHN
+
..
R
R
R
E
-iminium intermediate
Scheme 3. A plausible reaction mechanism.
London, UK, 1985; Chapter 3, pp 89–183; (e) Numata, A.; Ibuka, I.
In The Alkaloids; Brossi, A., Ed.; Academic: New York, 1987; Vol. 31,
pp 193–315; (f) Angle, R. S.; Breitenbucher, J. G. In Studies in Natural
Products Chemistry; Atta-ur-Rahman, Ed.; Stereoselective Synthesis
(Part J); Elsevier: Amsterdam, The Netherlands, 1995; Vol. 16, pp
453–502.
1, entries k–n). In the absence of gallium(III) iodide, no
aza-Prins-cyclization was observed even with stoichio-
metric amounts of iodine. The use of gallium(III) iodide
alone gave the products in low yields (20–35%). Therefore,
addition of 1 equiv. of iodine was crucial to obtain high
conversion. Thus, the combination of gallium(III) iodide
and iodine worked efficiently to furnish the corresponding
di- and tri-substituted piperidines in good to high yields.
The effects of various metal iodides such as GaI3, InI3,
AlI3, and MgI2 were screened. Of these metal iodides, gal-
lium(III) iodide was found to be superior in terms of con-
version. For example, the reaction between benzaldehyde
and N-tosylhomoallyl amine in the presence of 1 equiv of
molecular iodine and 10 mol % of metal iodides such as
GaI3, InI3, AlI3, and MgI2 gave product 3a, in 91%,
75%, 69%, and 62% yields, respectively. The combination
of 10 mol % of FeCl3 and 1 equiv of iodine also gave
4-iodopiperidines along with 4-chloropiperidines. In addi-
tion, N-tosyl deprotection was observed in aza-Prins-cycli-
zation when using FeCl3/I2. As solvent, dichloromethane
gave the best results. In all cases, the reactions proceeded
readily at room temperature under mild conditions to give
the products in good yields and with high diastereoselecti-
vity. The formation of the products may be explained by
initial aminal formation and subsequent Prins-type cycli-
zation (Scheme 3). The scope and generality of this process
is illustrated in Table 1.10
2. Gershwin, M. E.; Terr, A. Clin. Rev. Allergy Immunol. 1996, 14, 241.
3. (a) Micel, K.-H.; Sandberg, F.; Haglid, F.; Norin, T. Acta. Pharm.
Suec. 1967, 4, 97; (b) Micel, K.-H.; Sandberg, F.; Haglid, F.; Norin,
T.; Chan, R. P. K.; Craig, J. C. Acta Chem. Scand. 1969, 23, 3479.
4. (a) Laschat, S.; Dickner, T. Synthesis 2000, 1781–1813; (b) Bailey, P.
D.; Millwood, P. A.; Smith, P. D. Chem. Commun. 1998, 633–640; (c)
Weintraub, P. M.; Sabol, J. S.; Kane, J. M.; Borcherding, D. R.
Tetrahedron 2003, 59, 2953–2989; (d) Felpin, F.-X.; Lebreton, J. Eur.
J. Org. Chem. 2003, 3693–3712; (e) Couty, F. Amino Acids 1999, 16,
297–320. Interscience: New York, 1972; Vol. 2, pp 1–95.
5. Carballo, R. M.; Ramırez, M. A.; Rodrıguez, M. L.; Martın, V. S.;
Padron, J. I. Org. Lett. 2006, 8, 3837.
6. (a) Dobbs, A. P.; Guesne, S. J. J. Synlett 2005, 2101–2103; (b) Dobbs,
A. P.; Guesne, S. J. J.; Hursthouse, M. B.; Coles, S. J. Synlett 2003,
1740–1742; (c) Dobbs, A. P.; Guesne, S. J. J.; Martinovic, S.; Coles, S.
J.; Hursthouse, M. B. J. Org. Chem. 2003, 68, 7880–7883.
7. (a) Chatani, N.; Inoue, H.; Kotsuma, T.; Murai, S. J. Am. Chem. Soc.
2002, 124, 10294; (b) Yamaguchi, M.; Tsukagoshi, T.; Arisawa, M. J.
Am. Chem. Soc. 1999, 121, 4074; (c) Asao, N.; Asano, T.; Ohishi, T.;
Yamamoto, Y. J. Am. Chem. Soc. 2000, 122, 4817.
8. (a) Yadav, J. S.; Reddy, B. V. S.; Eeshwaraiah, B.; Gupta, M. K.;
Biswas, S. K. Tetrahedron Lett. 2005, 46, 1161; (b) Yadav, J. S.;
Reddy, B. V. S.; Padmavani, B.; Gupta, M. K. Tetrahedron Lett.
2004, 45, 7577.
9. (a) Yadav, J. S.; Subba Reddy, B. V.; Narayana Kumar, G. G. K. S.;
Swamy, T. Tetrahedron Lett. 2007, 48, 2205–2208; (b) Yadav, J. S.;
Subba Reddy, B. V.; Narayana Kumar, G. G. K. S.; Reddy, M. G.
Tetrahedron Lett. 2007, 48, 4903–4906; (c) Yadav, J. S.; Kumar, N.
N.; Reddy, M. S.; Prasad, A. R. Tetrahedron 2007, 63, 2689–2694; (d)
Yadav, J. S.; Reddy, B. V. S.; Maity, T.; Narayana Kumar, G. G. K.
S. Tetrahedron Lett. 2007, 48, 7155–7159.
In summary, we have developed an efficient protocol for
the synthesis of 2,4-di- and 2,4,6-trisubstituted piperidines
by means of aza-Prins-cyclization using gallium(III)
iodide/molecular iodine as a novel catalytic system. The
method is mild, selective, and convenient and the reaction
conditions are amenable to scale-up.
10. General procedure:
A mixture of homoallylic amine (1 mmol),
aldehyde (1 mmol), and gallium iodide (0.1 mmol) and iodine
(1.0 mmol) in dichloromethane (5 mL) was stirred at 23 °C for the
specified amount of time (Table 1). After completion of the reaction
as indicated by TLC, the reaction mixture was extracted with
dichloromethane (2 Â 10 mL). The combined organic layers were
dried over anhydrous Na2SO4. Removal of the solvent followed by
purification on silica gel (Merck, 60–120 mesh, ethyl acetate–hexane,
0.5–9.5) gave the pure 4-iodopiperidine. The products thus obtained
were characterized by IR, NMR, and mass spectroscopy. The spectral
data were found to be consistent with authentic samples. Compound
3a: 4-Iodo-1-(4-methylphenylsulfonyl)-2-phenylhexahydropyridine:
solid, mp 102–104 °C. IR (KBr): mmax 3029, 2924, 2870, 1598, 1494,
1448, 1336, 1285, 1156, 1091, 1059, 950, 930, 834, 701 cmÀ1. 1H NMR
(500 MHz, CDCl3): d 7.76 (d, J = 7.7 Hz, 2H, tos-o), 7.34 (m, 4H, tos-
m, Ph-m), 7.28 (m, 3H, Ph-o, p), 5.21 (br m, 1H, H2e), 4.13 (tt,
J = 12.6, 3.9, Hz, 1H, H4a), 3.74 (ddt, J = 14.8, 4.6, 2.3 Hz, 1H, H6e),
3.04 (ddd, J = 15.2, 12.6, 2.9 Hz, 1H, H6a), 2.95 (ddt, J = 13.4, 4.2,
2.1 Hz, 1H, H3e), 2.46 (s, 3H, CH3), 2.28 (dt, J = 5.4, 13.4 Hz, 1H,
H3a), 2.10 (m, 1H, H5e), 1.95 (dq, J = 4.6, ꢀ12.6 Hz, 1H, H5a). 13C
NMR (75 MHz, CDCl3): d 19.0, 21.6, 38.0, 40.6, 43.4, 57.6, 126.6,
Acknowledgements
DNC, GGKSNK and SA thank CSIR, New Delhi, for
the award of fellowships and also thank DST for the finan-
cial assistance under the J. C. Bose fellowship scheme.
References and notes
1. (a) Jones, T. H.; Blum, M. S. In Alkaloids: Chemical and Biological
Perspectives; Pelletier, S. W., Ed.; Wiley: New York, 1983; Vol. 1,
Chapter 2, pp 33–84; (b) Fodor, G. B.; Colasanti, B.. In Alkaloids:
Chemical and Biological Perspectives; Pelletier, S. W., Ed.; Wiley: New
York, 1985; Vol. 3, Chapter 1, pp 1–90; (c) Schneider, M. J. In
Alkaloids: Chemical and Biological Perspectives; Pelletier, S. W., Ed.;
Wiley: New York, 1996; Vol. 10, Chapter 3, pp 155–315; (d) Strunz,
G. M.; Findlay, J. A. In The Alkaloids; Brossi, A., Ed.; Academic: